Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Bonnie Ky"'
Autor:
Biniyam G. Demissei, William P. Levin, Amit Maity, Abigail T. Berman, Keith A. Cengel, Sheela Krishnan, Bonnie Ky, Steven J. Feigenberg, Samuel Swisher-McClure, Gary M. Freedman, John P. Plastaras, Hari K. Narayan, Amanda M. Smith
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 109:946-952
The effects of thoracic radiation therapy (RT) on physical functioning and quality of life (QoL) are incompletely defined. We determined the associations between thoracic RT dose volume metrics, physical activity, and QoL in patients with cancer.Part
Autor:
Anastasia Velalopoulou, Denisa Goia, Constantinos Koumenis, Scott D. Metzler, Bonnie Ky, Ioannis I. Verginadis, Susan Mazzoni, Steven J. Feigenberg, Paco E Bravo, Harris Avgousti, Swapnil V. Shewale, Khayrullo Shoniyozov, Alexandra D. Dreyfuss
Publikováno v:
Clin Cancer Res
Purpose: Radiation-induced cardiotoxicity is a significant concern in thoracic oncology patients. However, the basis for this disease pathology is not well characterized. We developed a novel mouse model of radiation-induced cardiotoxicity to investi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5314993bd17076419a6ffea2b5c6ed4b
https://europepmc.org/articles/PMC9215266/
https://europepmc.org/articles/PMC9215266/
Autor:
John P. Plastaras, Bonnie Ky, Suparna C. Clasen, Neil K. Taunk, Boon-Keng Kevin Teo, Haochang Shou, Gary M. Freedman, Biniyam G. Demissei, Amanda M. Smith
Publikováno v:
International journal of radiation oncology, biology, physics. 109(5)
Purpose To characterize the early changes in echocardiographically derived measures of cardiac function with contemporary radiation therapy (RT) in breast cancer and to determine the associations with radiation dose-volume metrics, including mean hea
Autor:
Christy Kesslering, Amy Berrington de Gonzalez, Suneel Nagda, Christine D. Berg, Karen D. Schupak, Elizabeth A. Hahn, Shannon M. MacDonald, Bonnie Ky, Cynthia Chauhan, Robert W. Mutter, Alphonse G. Taghian, Hien L. Lu, Stephanie L. Pugh, Kaysee Baker, Simon N. Powell, M. Pankuch, L. Christine Fang, Justin E. Bekelman, Mark V. Mishra, Rachel B. Jimenez, Choonsik Lee, Atif J. Khan, Fred W. Prior, Gary M. Freedman, J. Ben Wilkinson, Susan S. Ellenberg, Lior Z. Braunstein, Hsiao-Ming Lu, C. Daniel Mullins, Walter R. Bosch, Oren Cahlon, Bruce G. Haffty
Publikováno v:
BMJ Open
IntroductionA broad range of stakeholders have called for randomised evidence on the potential clinical benefits and harms of proton therapy, a type of radiation therapy, for patients with breast cancer. Radiation therapy is an important component of
Autor:
Justin C. Brown, Andrea B. Troxel, Michael R. Rickels, Anil K. Rustgi, Kathryn H. Schmitz, Nevena Damjanov, Babette S. Zemel, Bonnie Ky, Andrew D. Rhim, Kerry S. Courneya
Publikováno v:
Endocrine-Related Cancer. 25:11-19
Physical activity is associated with a lower risk of disease recurrence among colon cancer survivors. The pathways through which physical activity may alter disease outcomes are unknown, but may include changes in metabolic growth factors, such as in
Autor:
Eric J. Chow, Gregory T. Armstrong, Thomas J. Ryan, Daniel A. Mulrooney, Paul C. Nathan, Saro H. Armenian, Bonnie Ky, Helena J H van der Pal, Javid Moslehi, Gregory J. Aune, Matthew J. Ehrhardt, Leontien C. M. Kremer, Elvira C. van Dalen
Publikováno v:
Journal of clinical oncology. 36(21):2135-2144
Cardiovascular disease (CVD), which includes cardiomyopathy/heart failure, coronary artery disease, stroke, pericardial disease, arrhythmias, and valvular and vascular dysfunction, is a major concern for long-term survivors of childhood cancer. There
Autor:
Rupal O'Quinn, Suparna C. Clasen, Joseph R. Carver, Ursina R. Teitelbaum, Bonnie Ky, Bruce Giantonio
Publikováno v:
Journal of Gastrointestinal Oncology. 8:970-979
Background: Fluoropyrimidine chemotherapy [5-fluorouracil (5-FU) and capecitabine] are commonly used agents in the treatment of various solid malignancies. However, their use has been limited by cardiac toxicity, presenting as a wide spectrum of asym
Autor:
Martin S. Tallman, James M. Foran, Jonathan Canaani, Bonnie Ky, Vera H. Rigolin, Jessica K. Altman, Woo Bin Voss, Nausheen Akhter, Selina M. Luger, Gregory Cascino, Nicholas Furiasse, Alfred Rademaker, Mark R. Litzow
Publikováno v:
Echocardiography
Background: Patients with acute myeloid leukemia (AML) are surviving longer. There are no data on changes in myocardial mechanics from standard of care low-dose anthracycline-based induction chemotherapy in older patients with AML. The aim of this st
Autor:
John McCaffrey, Mairin Rafferty, Michael J. Kennedy, M. Keane, Miriam O'Connor, Ashwini Maratha, Enda W. McDermott, Paul Donnellan, Oscar Breathhnach, D. Tryfonopoulos, John Crown, Paula Calvert, Rajnish Gupta, Giuseppe Gullo, Verena Murphy, Denis M. Collins, G. Leonard, Annette T. Byrne, Imelda Parker, Kathleen Scott, David W. Murray, Bonnie Ky, Michael J. Martin, Patrick Dicker, Alexandra Canonici, Norma O'Donovan, Liam Grogan, Andres Hernando, Alex J Eustace, Brian Moulton, Alice C. O’Farrell, William M. Gallagher, Janice M. Walshe
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 11 (2019)
Therapeutic Advances in Medical Oncology
Therapeutic Advances in Medical Oncology
Background: Combining bevacizumab and chemotherapy produced superior response rates compared with chemotherapy alone in metastatic breast cancer. As bevacizumab may cause hypertension (HTN) and increase the risk of cardiac failure, we performed a pil
Publikováno v:
Gynecologic Oncology Research and Practice
Gynecologic Oncology Research and Practice, Vol 5, Iss 1, Pp 1-10 (2018)
Gynecologic Oncology Research and Practice, Vol 5, Iss 1, Pp 1-10 (2018)
Combretastatin A4-phosphate (CA4P) is a vascular-disrupting agent (VDA) in clinical development for the treatment of ovarian and other cancers. In contrast to antiangiogenic agents, such as bevacizumab, which suppress the development of new tumor vas